Predictors of attrition in a randomized controlled trial of an electronic nicotine delivery system among people interested in cigarette smoking reduction

被引:0
|
作者
Cobb, Caroline O. [1 ,2 ]
Budd, Serenity [5 ]
Maldonado, Gabrielle [1 ,2 ]
Imran, Rabia [1 ,2 ]
Foulds, Jonathan [3 ,4 ]
Yingst, Jessica [3 ,4 ]
Yen, Miao-Shan [2 ,5 ]
Kang, Le [5 ]
Sun, Shumei [5 ]
Hall, Phoebe Brosnan [6 ]
Chowdhury, Nadia [7 ]
Cohen, Joanna E. [8 ]
机构
[1] Virginia Commonwealth Univ, Dept Psychol, 612 N Lombardy St, Richmond, VA 23284 USA
[2] Virginia Commonwealth Univ, Ctr Study Tobacco Prod, 100 West Franklin St,Suite 200, Richmond, VA 23220 USA
[3] Penn State Univ, Ctr Res Tobacco & Hlth, Coll Med, 30 Long Lane, Hershey, PA 17036 USA
[4] Penn State Univ, Dept Publ Hlth Sci, Coll Med, 700 HMC Crescent Rd, Hershey, PA 17033 USA
[5] Virginia Commonwealth Univ, Dept Biostat, One Capital Sq 830 East Main St, Richmond, VA 23219 USA
[6] Boston Univ, Dept Psychol & Brain Sci, 64 Cummington Mall 149, Boston, MA 02215 USA
[7] NYU Langone Hlth, 550 First Ave, New York, NY 10016 USA
[8] Johns Hopkins Bloomberg Sch Publ Hlth, Inst Global Tobacco Control, Dept Hlth Behav & Soc, Baltimore, MD USA
基金
美国国家卫生研究院;
关键词
Electronic nicotine delivery system; Smoking; Retention; Clinical trial; Attrition; LIQUID NICOTINE; CLINICAL-TRIAL; PARALLEL-GROUP; LOW-INCOME; QUESTIONNAIRE; STRATEGIES; PRODUCT;
D O I
10.1016/j.cct.2024.107662
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Background: Mitigating attrition is a key component to reduce selection bias in longitudinal randomized controlled trials (RCTs). Few studies of electronic nicotine delivery systems (ENDS) allow for the examination of long-term retention. This analysis explores the relationship between attrition, baseline measures, and condition assigned for a RCT involving ENDS differing in nicotine delivery over a 24-week intervention period. Methods: Participants (N = 520) who smoked >= 10 cigarettes per day [CPD] for >= 1 year and reported interest in reducing but not quitting were randomized to 1 of 4 conditions: an ENDS containing 0, 8, or 36 mg/ml liquid nicotine (administered double-blind) or a cigarette-shaped plastic tube. Cox proportional hazards regression models were fit to examine attrition over time and predictors of attrition including baseline characteristics and condition. A stepwise approach was used to determine the final model; alpha was set at 0.05. Results: Attrition did not differ significantly by condition (223/520), and most (69%) were lost-to-follow-up. Only age, education level, and household income were significantly predictive of attrition. For every additional year of age, attrition risk fell by 3%. Holding a bachelor's degree or higher was associated with reduced attrition risk. Those with the lowest income (<$10 K) were more likely to be withdrawn compared to those earning $10 K-39 K, and those with the highest income ($100 K+) were more likely to be withdrawn compared with the latter bracket and those earning $70-99 K. Conclusion: ENDS nicotine content did not drive differential attrition in this trial, and targeted retention efforts are needed for specific subgroups.
引用
收藏
页数:6
相关论文
共 50 条
  • [41] Clinical study protocol on electronic cigarettes and nicotine pouches for smoking cessation in Pakistan: a randomized controlled trial
    Hameed, Abdul
    Malik, Daud
    TRIALS, 2024, 25 (01)
  • [42] Author Correction: Electronic cigarettes versus nicotine patches for smoking cessation in pregnancy: a randomized controlled trial
    Peter Hajek
    Dunja Przulj
    Francesca Pesola
    Chris Griffiths
    Robert Walton
    Hayden McRobbie
    Tim Coleman
    Sarah Lewis
    Rachel Whitemore
    Miranda Clark
    Michael Ussher
    Lesley Sinclair
    Emily Seager
    Sue Cooper
    Linda Bauld
    Felix Naughton
    Peter Sasieni
    Isaac Manyonda
    Katie Myers Smith
    Nature Medicine, 2023, 29 : 2957 - 2957
  • [43] Clinical and immunological peri-implant parameters among cigarette and electronic smoking patients treated with photochemotherapy: A randomized controlled clinical trial
    Al Deeb, Modhi
    Alresayes, Saad
    Mokeem, Sameer A.
    Alhenaki, Aasem M.
    AlHelal, Abdulaziz
    Shafqat, Syed Saad
    Vohra, Fahim
    Abduljabbar, Tariq
    PHOTODIAGNOSIS AND PHOTODYNAMIC THERAPY, 2020, 31
  • [44] The relationship between nicotine metabolism and nicotine and carcinogen exposure among American Indian commercial cigarette smokers and electronic nicotine delivery system users
    Carroll, Dana Mowls
    Wagener, Theodore L.
    Stephens, Lancer D.
    Brame, Lacy S.
    Thompson, David M.
    Beebe, Laura A.
    ADDICTIVE BEHAVIORS, 2019, 92 : 58 - 63
  • [45] Predictors of smoking cessation among African-Americans enrolled in a randomized controlled trial of bupropion
    Harris, KJ
    Okuyemi, KS
    Catley, D
    Mayo, MS
    Ge, B
    Ahluwalia, JS
    PREVENTIVE MEDICINE, 2004, 38 (04) : 498 - 502
  • [46] Randomized controlled trial to evaluate tooth stain reduction with nicotine replacement gum during a smoking cessation program
    Helen Whelton
    Rose Kingston
    Denis O’Mullane
    Frederick Nilsson
    BMC Oral Health, 12
  • [47] Randomized controlled trial to evaluate tooth stain reduction with nicotine replacement gum during a smoking cessation program
    Whelton, Helen
    Kingston, Rose
    O'Mullane, Denis
    Nilsson, Frederick
    BMC ORAL HEALTH, 2012, 12
  • [48] A SMOKING INTERVENTION AMONG PEOPLE WITH PSYCHOTIC DISORDERS - PRELIMINARY RESULTS FROM A RANDOMIZED CONTROLLED TRIAL
    Baker, Amanda
    Richmond, Robyn
    Kay-Lambkin, Frances
    Filia, Sacha
    Castle, David
    Williams, Jill
    Clark, Vanessa
    Lewin, Terry
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2012, 8 : 339 - 339
  • [49] Tobacco Harm Reduction with Vaporised Nicotine (THRiVe): A Feasibility Trial of Nicotine Vaping Products for Smoking Cessation Among People Living with HIV
    Stephanie Edwards
    Cheneal Puljević
    Judith A. Dean
    Charles Gilks
    Mark A. Boyd
    Peter Baker
    Peter Watts
    Chris Howard
    Coral E. Gartner
    AIDS and Behavior, 2023, 27 : 618 - 627
  • [50] Tobacco Harm Reduction with Vaporised Nicotine (THRiVe): A Feasibility Trial of Nicotine Vaping Products for Smoking Cessation Among People Living with HIV
    Edwards, Stephanie
    Puljevic, Cheneal
    Dean, Judith A.
    Gilks, Charles
    Boyd, Mark A.
    Baker, Peter
    Watts, Peter
    Howard, Chris
    Gartner, Coral E.
    AIDS AND BEHAVIOR, 2023, 27 (02) : 618 - 627